GSK and Fleming Initiative scientists unite to target AMR with advanced AI
Imperial wins Outstanding Entrepreneurial University at THE Awards
Imperial celebrates impact of supporters who gave £77.5 million in 2024-25
We help university ventures hit the milestones that matter to early-stage investors, supporting better-prepared teams, clearer value propositions, and more investable science.
We support investors backing science-based ventures to strengthen investment outcomes, with the goal of enabling more risk capital to flow into the sector.
We provide insights to help policymakers design smarter funding, procurement, and regulatory strategies that unlock value from science-led innovation.